Brown University will name its emerging research center focused on RNA science the Giuliani RNA Center, in recognition of a gift from health care investor and Brown trustee Giammaria Giuliani and his wife, Sabrina.
Over 3,000 riders, runners, walkers, and spinners joined forces at UC San Diego last month for the 2025 Curebound Cancer Challenge (formerly Padres Pedal the Cause), generating $4 million to advance cancer research in the San Diego region.
The Parker Institute for Cancer Immunotherapy, a collaborative consortium of immuno-oncology experts that bridges scientific discovery and commercialization of cancer therapies, announced its 2025 class of Early Career Researcher awardees.
Thyme Care has announced a $97M Series D fundraise from current investors CVS Health Ventures, Foresite Capital, a16z Bio + Health, Concord Health Partners, Town Hall Ventures, AlleyCorp, and Frist Cressey Ventures. New strategic investors include Morgan Health, a division of JPMorganChase focused on employer-sponsored healthcare, as well as Humana, Texas Oncology, and Memorial Hermann Health System, bringing Thyme Care’s total capital raised to $275M.
Montefiore Einstein Comprehensive Cancer Center announced that its lung cancer team has been recognized by the International Association for the Study of Lung Cancer for delivering outstanding care. The announcement was made during the IASLC annual meeting in Barcelona.
The Northwell Cancer Institute has unveiled its Center for Women’s Cancer at the R.J. Zuckerberg Cancer Center.
The University of Cincinnati Cancer Center’s Joan Garrett has received a two-year, $162,000 NCI grant to study a new combination approach to treat KRAS-mutated colorectal cancers.
Monica Bertagnolli, former director of NIH and NCI, is on the path to becoming the next president of the National Academy of Medicine.
Break Through Cancer has launched the Defying Osteosarcoma TeamLab, an initiative that brings together more than 20 researchers from eight institutions in a coordinated, multi-year effort focused on improving pediatric osteosarcoma care.
Twelve leading research teams from around the world have been shortlisted for Cancer Grand Challenges’ fifth funding round. The teams will present final proposals to a panel of leading international scientists in December, with winners receiving up to £20 million each.
